# Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

> **NCT00202293** · PHASE4 · COMPLETED · sponsor: **Melbourne Health** · enrollment: 83 (actual)

## Conditions studied

- Bipolar Disorder
- Schizoaffective Disorder

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Lithium
- **DRUG:** Chlorpromazine

## Key facts

- **NCT ID:** NCT00202293
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10-01
- **Primary completion:** 2015-11-01
- **Final completion:** 2015-11-01
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202293, "Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00202293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*